Related by context. Frequent words. (Click for all words.) 62 Smallpox Vaccine 62 Cervical Cancer Vaccine 61 Anthrax Vaccine 60 Cholesterol Drug 60 Prostate Cancer Patients 60 Patient Enrollment 60 Phase III Clinical Trial 60 Generic Version 60 FDA Accepts 59 RNAi Therapeutics 59 Improves Survival 59 Exclusive License 59 Single Dose 59 Malaria Vaccine 59 Patent Covering 58 Atopic Dermatitis 58 Workforce Reduction 58 Small Molecule 58 Pulmonary Arterial Hypertension 58 Breast Cancer Treatment 58 Cancer Treatments 58 Cancer Vaccines 58 Influenza Vaccine 57 Therapeutic Discovery Project 57 Advanced Prostate Cancer 57 Prostate Cancer Treatment 57 Sustained Growth 57 FDA Orphan Drug 57 Flu Vaccines 57 Drug Candidate 57 Clinical Outcomes 57 Pediatric Patients 57 Marketing Authorisation 57 Antiretroviral 57 Low Dose 57 Gastric Cancer 57 Clinical Trial Results 56 Adverse Reactions 56 Renal Cell Carcinoma 56 Cancer Vaccine 56 Early Diagnosis 56 Pivotal Study 56 FDA Clearance 56 Phase III Trial 56 Preclinical Data 56 Combination Therapy 56 Aliskiren 56 Significantly Reduces 56 Overactive Bladder 56 Cost Effectiveness 55 Antifungal 55 Blood Thinner 55 Anticoagulation 55 Better Outcomes 55 Study Demonstrates 55 Anti Inflammatory 55 Virtual Colonoscopy 55 Pivotal Trial 55 Extended Release 55 Regimens 55 Medication Errors 55 Positive Opinion 54 Allergic Rhinitis 54 FDA Clears 54 Develop Novel 54 Autoimmune Diseases 54 Patients Treated 54 Autoimmune Disease 54 Anticancer 54 Significantly Improves 54 Bevacizumab 54 Etanercept 54 Post Operative 54 Metastatic Melanoma 53 Generic Drug 53 Biosimilar 53 Contraindications 53 Fast Track Designation 53 Pivotal Phase 53 Commercialization Agreement 53 Radiation Exposure 53 Reauthorize 53 Antiviral 53 Tumor Growth 53 Genetic Testing 53 Drug Makers 53 Broadened 53 Antipsychotic 53 Biosimilars 53 FDAAA 53 Heart Failure Patients 53 Racial Disparities 53 Ethanol Production 53 Patient Outcomes 52 Colorectal Cancer Screening 52 Peer Reviewed 52 Medicare Beneficiaries 52 Monoclonal Antibody 52 Long Lasting 52 Related Costs 52 Reduces Risk